Join
Live feed
·
PRReleasevia Quantisnow
Eagle Pharmaceuticals Inc. logo

Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years

ByQuantisnow·Wall Street's wire, on your screen.
EGRX· Eagle Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EGRX (Eagle Pharmaceuticals Inc.) and more on Quantisnow.